Table 2.
Symptom Management Behaviors by Group at Follow-Up
Pilot 1 (N = 41) | Pilot 2 (N = 20) | Pilot 3 (N = 21) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
IRIS | Control | IRIS | Control | IRIS | ||||||
Variable | n | % | n | % | n | % | n | % | n | % |
Discussed symptom with healthcare provider |
16 | 80 | 13 | 68 | 9 | 100* | 5 | 56 | 19 | 95 |
Began new medical treatment | 12 | 60 | 6 | 32 | 8 | 89* | 3 | 33 | 11 | 55 |
Improved with new treatment | 8 | 57 | 6 | 100 | 7 | 100* | 1 | 50 | 11 | 100 |
Changed self-care of symptom | 15 | 75** | 5 | 26 | 9 | 100** | 1 | 11 | 17 | 85 |
• Found it helpful | 14 | 93* | 3 | 60 | 7 | 88 | 0 | 0 | 17 | 100 |
Talked with family and friends about symptom |
15 | 75 | 10 | 53 | 5 | 56 | 5 | 56 | 15 | 75 |
• Found it helpful | 1 | 87 | 8 | 57 | 5 | 100 | 4 | 80 | 15 | 100 |
Used other sources of information | 9 | 45 | 6 | 32 | 4 | 44 | 3 | 33 | 12 | 60 |
• Found it helpful | – | – | – | – | 4 | 100 | 2 | 67 | 12 | 100 |
p < 0.05
p <0.01
IRIS—individualized representational intervention to improve symptom management
Note. Follow-up measures at 10 weeks (pilot 1) or 16 weeks (pilots 2 and 3)
Note. Percentages were computed based on valid cases for each group.